serenoa repens fruit

powder obtained from the dried, ground fruit of the saw palm, serenoa serrulata, palmaceae

CAS: 84604-15-9

Identification

Nameserenoa repens fruit
CAS Number84604-15-9
FDA UNIISearch

Regulatory

Physical Properties

Food Chemicals Codex Listed No

Cosmetic Information

CosIngcosmetic data
Cosmetic Usesskin conditioning

No sensory data available

Safety Information

Oral/Parenteral ToxicityNot determined
Dermal ToxicityNot determined
Inhalation ToxicityNot determined

GHS Classification

['GHS Classification in accordance with 29 CFR 1910 (OSHA HCS)', 'GHS Label elements, including precautionary statements']

Safety in Use

Categorycosmetic ingredient for skin conditioning
Recommendation for serenoa repens fruit usage levels up tonot for fragrance use.
Recommendation for serenoa repens fruit flavor usage levels up tonot for flavor use.

No supplier data available

Potential Uses

None Found

Natural Occurrence

saw palmetto fruit

Synonyms

powder obtained from the dried, ground fruit of the saw palm, serenoa serrulata, palmaceae sabal serrulatum fruit saw palmetto berries saw palmetto berry serenoa serrulata fruit PubMed: Effect of Epilobium angustifolium and Serenoa repens extracts on regulation of non-genomic signaling pathway of kinases. PubMed: DNA barcode authentication of saw palmetto herbal dietary supplements. PubMed: Observational database serenoa repens (DOSSER): overview, analysis and results. A multicentric SIUrO (Italian Society of Oncological Urology) project. PubMed: Effect of increasing doses of saw palmetto extract on lower urinary tract symptoms: a randomized trial. PubMed: Saw palmetto. Serenoa repens. Also known as Serenoa serrulata, Sabal serrulata and the dwarf palm. PubMed: Redesigning a large-scale clinical trial in response to negative external trial results: the CAMUS study of phytotherapy for benign prostatic hyperplasia. PubMed: Analysis of the hydrodistillate from the fruits of Serenoa repens. PubMed: Development of saw palmetto (Serenoa repens) fruit and extract standard reference materials. PubMed: Effects of D-004, a lipid extract of the fruit of the Cuban royal palm (Roystonea regia) or the lipidosterolic extract of saw palmetto (Serenoa repens) on the sexual activity in male rats: A controlled, experimental study. PubMed: Evaluation of cell death caused by an ethanolic extract of Serenoae repentis fructus (Prostasan) on human carcinoma cell lines. PubMed: Hepatotoxicity potential of saw palmetto (Serenoa repens) in rats. PubMed: Effect of D-004, a lipid extract from the Cuban royal palm fruit, on atypical prostate hyperplasia induced by phenylephrine in rats. PubMed: Updated meta-analysis of clinical trials of Serenoa repens extract in the treatment of symptomatic benign prostatic hyperplasia. PubMed: Comparison of Saw Palmetto (extract and whole berry) and Cernitin on prostate growth in rats. PubMed: Botanical medicines for the urinary tract. PubMed: Extracts from fruits of saw palmetto (Sabal serrulata) and roots of stinging nettle (Urtica dioica): viable alternatives in the medical treatment of benign prostatic hyperplasia and associated lower urinary tracts symptoms. PubMed: Combined sabal and urtica extract compared with finasteride in men with benign prostatic hyperplasia: analysis of prostate volume and therapeutic outcome. PubMed: Meta-analysis of clinical trials of permixon in the treatment of symptomatic benign prostatic hyperplasia. PubMed: Derivatization for electrospray ionization mass spectrometry. 3. Electrochemically ionizable derivatives. PubMed: [Anti-inflammatory activity of sabal fruit extracts prepared with supercritical carbon dioxide. In vitro antagonists of cyclooxygenase and 5-lipoxygenase metabolism]. PubMed: [Anti-edematous action of a hexane extract of the stone fruit of Serenoa repens Bartr]. PubMed: A note on the effects of feeding saw palmetto berries, Serenoa repens (Bartram) Small, to rats.